Comparison of Aripiprazole and Risperidone in the Treatment of Female Schizophrenia
Xiaoli Hu
Abstract
Xiaoli Hu
Abstract
Objective To compare the clinical and safety between aripiprazole and risperidone in the treatment of female patients with schizophrenia.Methods 80 female patients with schizophrenia were randomly divided into aripiprazole group and risperidone group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and adverse.Results There was a similar efficacy between the two groups,group of aripiprazole had fewer or slighter side effects.Conclusion The effects of aripiprazole to endocrine and weight were smaller than those of risperidone.Aripiprazole is a safe and effective antipsychotics with good compliance.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the clinical and safety between aripiprazole and risperidone in the treatment of female patients with schizophrenia.Methods 80 female patients with schizophrenia were randomly divided into aripiprazole group and risperidone group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and adverse.Results There was a similar efficacy between the two groups,group of aripiprazole had fewer or slighter side effects.Conclusion The effects of aripiprazole to endocrine and weight were smaller than those of risperidone.Aripiprazole is a safe and effective antipsychotics with good compliance.
Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Medicine, Adverse effect, Internal medicine, Psychiatry, Psychology